Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2008-05-07
2010-02-09
Wilson, James O (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
07659395
ABSTRACT:
Urea derivatives which comprise compounds of the formulawherein A is H, B is piperidine and each Ar is phenyl are disclosed as useful in treating conditions such as pain, epilepsy, diabetes or prostate cancer.
REFERENCES:
patent: 5428038 (1995-06-01), Chatterjee et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5703071 (1997-12-01), Itoh et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6294533 (2001-09-01), Snutch et al.
patent: 6310059 (2001-10-01), Snutch
patent: 6458781 (2002-10-01), Connor et al.
patent: 6492375 (2002-12-01), Snutch
patent: 6943168 (2005-09-01), Snutch et al.
patent: 6949554 (2005-09-01), Snutch et al.
patent: 6951862 (2005-10-01), Snutch et al.
patent: 2002/0019389 (2002-02-01), Kim
patent: 2004/0034035 (2004-02-01), Snutch et al.
patent: 2004/0044004 (2004-03-01), Snutch et al.
patent: 2004/0147529 (2004-07-01), Snutch et al.
patent: 2004/0192703 (2004-09-01), Snutch et al.
patent: 2004/0259866 (2004-12-01), Snutch et al.
patent: 2004/0266784 (2004-12-01), Snutch et al.
patent: 2006/0084660 (2006-04-01), Snutch et al.
patent: 2 335 461 (2000-01-01), None
patent: 0 441 226 (1991-08-01), None
patent: WO-97/24325 (1997-07-01), None
patent: WO-00/01375 (2000-01-01), None
patent: WO-01/45709 (2001-06-01), None
patent: WO-01/46166 (2001-06-01), None
patent: WO-01/49670 (2001-07-01), None
patent: WO-01/95856 (2001-12-01), None
patent: WO-2004/089377 (2004-10-01), None
patent: WO-2004/089922 (2004-10-01), None
MeSH, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=mesh&Cm...ystem2.PEntrez.Mesh.Mesh—ResultsPanel.Mesh—RVDocSum, accessed Nov. 12, 2008.
March. Advanced Organic Chemistry, 1992, pp. 352-357 and 649-651.
Carceller et al. Journal of Medicinal Chemistry, 1992, 35, 4118-34.
Augustine et al., Annu. Rev. Neurosci. (1987) 10:633-693.
Backonja et al., JAMA (1998) 280:1831-1836.
Bowersox et al., J. Pharmacol. Exp. Ther. (1996) 279:1243-1249.
Caraceni et al., J. Pain & Symp. Manag. (1999) 17:441-445.
Catterall, Annu. Rev. Cell Dev. Biol. (2000) 16:521-555.
Cesena, Neuro. Sci. Lett. (1999) 262:101-104.
Cheng et al., Anesthesiology (2000) 92:1126-1131.
Di Trapani et al., Clin. Ter. (2000) 151:145-148.
Dogrul et al., Pain (2003) 105:159-168.
Dooley, Current Opinion in CPNS Investigational Drugs (1999) 1:116-125.
Field et al., Pain (1999) 80:391-398.
Gomora et al., Mol. Pharmacol. (2001) 60:1121-1132.
Gould et al., PNAS USA (1983) 80:5122-5125.
Grantham et al., Brit. J. Pharmacol. (1944) 111:483-488.
Hatakeyama et al., Neuro Report (2001) 12:2423-2427.
Heading, Curr. Opin. CPNS Investigational Drugs (1999) 1:153-166.
Heady et al., Jpn. J. Pharmacol. (2001) 85:339-350.
Houtchens et al., Multiple Sclerosis (1997) 3:250-253.
Huguenard, Annu. Rev. Physiol. (1996) 58:329-348.
Ino et al., PNAS USA (2001) 98:5323-5328.
International Search Report for PCT/CA2005/001324, mailed on Dec. 14, 2005, 6 pages.
Kim et al., Mol. Cell Neurosci. (2001) 18:235-245.
Kim et al., Neuron (2001) 31:35-45.
King et al., J. Biol. Chem. (1989) 264:5633-5641.
Laird et al., Annal. Pharmacotherap. (2000) 34:802-807.
Lavoie and Patani, Chemical Reviews (1996) 96:3147-3176.
Magnus, Epilepsia (1999) 40:S66-S72.
Malmberg et al., J. Neurosci. (1994) 14:4882-4890.
Mathur, Seminars in Anesthesia, Perioperative Medicine and Pain (2000) 19:67-75.
Miller, Science (1987) 235:46-52.
Nicholson, Acta. Neurol. Scand. (2000) 101:359-371.
Ridgeway et al., Pain (2000) 85:287-289.
Rowbotham et al., JAMA (1998) 280:1837-1842.
Saegusa et al., PNAS USA (2001) 97:6132-6137.
Sluka, J. Pharmacol. Exp. Ther. (1998) 287:232-237.
Stea et al., Handbook on Ion Channels, R.A. North (ed.), CRC Press, (1994) pp. 113-151.
Stea et al., PNAS USA (1994) 91:10576-10580.
Su et al., J. Neurosci. (2002) 22:3645-3655.
Taylor et al., Epilepsy Res. (1998) 29:233-249.
Vanegas et al., Pain (2000) 85:9-18.
Wang et al., Soc. Neurosci. Abstr. (1998) 24:1626.
Ameliorate, retrieved online at <http://www.merriam-webster.com/dictionary/ameliorate>, accessed Dec. 8, 2008.
Cardiovascular Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi>, accessed Dec. 8, 2008.
Female Urogenital Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=23878&field=all&HM=&II=&PA=&form=&input=>, accessed Dec. 8, 2008.
Gastrointestinal Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=5541&field=all&HM=&II=&PA=&form=&input=>, accessed Dec. 8, 2008.
Gribkoff et al., Expert Opinion in Investigational Drugs (2005) 14(5):579-592.
Male Urogenital Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=23886&field=all&HM=&II=&PA=&form=&input=>, accessed Dec. 8, 2008.
Metabolic Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi>, accessed Dec. 8, 2008.
Mood Disorders, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi>, accessed Dec. 8, 2008.
Neurodegenerative Diseases, retrieved online at <http://www.nlm.nih.gov/cgi/mesh/2008/MB—cgi>, accessed Dec. 8, 2008.
Non-Final Office Action for U.S. Appl. No. 12/111,131, mailed on Dec. 18, 2008, 10 pages.
Sleep Disorders, retrieved online at <http://www.nlm. nih.gov/cgi/mesh/2008/MB—cgi?mode=&index=12386&field=all&HM=&II=&PA=&form=&input=>, accessed Dec. 8, 2008.
Collins et al., Expert Opinion on Emerging Drugs (2005) 10(1):95-108.
Diabetes, Gestational, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes,+Gestational&field=entry, accessed May 26, 2009.
Diabetes Insipidus, http:/
lm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&index=3759&field=all&HM=&II=&PA=&form=&input=, accessed May 26, 2009.
Diabetes, Insipidus, Nephrogenic, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Insipidus,+Nephrogenic&field=entry, accessed May 26, 2009.
Diabetes, Insipidus, Neurogenic, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Insipdus,+Neurogenic&field=entry, accessed May 26, 2009.
Diabetes Mellitus, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Mellitus&field=entry, accessed May 26, 2009.
Diabetes Mellitus, Experimental, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Mellitus,+Experimental&field=entry, accessed May 26, 2009.
Diabetes Mellitus, Lipoatrophic, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&index=3763&field=all&HM=&II=&PA=&form=&input, accessed May 26, 2009.
Diabetes Mellitus, Type 1, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Mellitus,+Type+1&field=entry, accessed May 26, 2009.
Diabetes Mellitus, Type 2, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Diabetes+Mellitus,+Type+2&field=entry, accessed May 26, 2009.
Dutta et al., Journal of Medicinal Chemistry (2001) 44(6):937-948.
Epilepsy, retrieved online at http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi, accessed May 26, 2009.
Epilepsy, Generalized, retrieved online at http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Epilepsy,+Generalized&field=entry, accessed May 26, 2009.
Epilepsy-Prevention, retrieved online at http://www.webmd.com/epilepsy/tc/epilepsy-prevention, accessed May 26, 2009.
Epilepsies, Myoclonic, retrieved online at http:/
lm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Epilepsies,+Myoclonic&field=entry, accessed May 26, 2009.
Epilepsies, Post-Traumatic, http://www.nlm.nih,gov/cgi/mesh/2009/MB—cgi?mode=&term=Epilepsy,+Post-Traumatic&field=entry, accessed May 26, 2009.
Epilepsy, Reflex, http://www.nlm.nih.gov/cgi/mesh/2009/MB—cgi?mode=&term=Epilepsy,+Reflex&field=entry, accessed May 26, 2009.
Final Office Action for U.S
Ding Yanbing
Pajouhesh Hassan
Pajouhesh Hossein
Snutch Terrance P.
Jarrell Noble
Morrison & Foerster / LLP
Neuromed Pharmaceuticals Ltd.
Wilson James O
LandOfFree
Urea derivatives as calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea derivatives as calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea derivatives as calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157662